The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: March 2018

Symbiotix Biotherapies Announces License Agreement with Harvard University
Pharma & Human Health

Symbiotix Biotherapies Announces License Agreement with Harvard University

MAR 21, 2018
AOBiome Therapeutics Reports Positive Clinical Safety Results for First-in-Class Microbiome-Targeted Therapy for Intranasal Delivery
Clinical & Manufacturing

AOBiome Therapeutics Reports Positive Clinical Safety Results for First-in-Class Microbiome-Targeted Therapy for Intranasal Delivery

MAR 21, 2018
Morinaga Milk’s New Probiotic Strain, Bifidobacterium breve A1, May Prevent Onset of Alzheimer’s Disease
Biotics and Supplements

Morinaga Milk’s New Probiotic Strain, Bifidobacterium breve A1, May Prevent Onset of Alzheimer’s Disease

MAR 20, 2018
Adisseo and Seventure Partners Announce €24m First Close of AVF, a New Fund Dedicated to Innovative Animal Health and Nutrition
Animal Health

Adisseo and Seventure Partners Announce €24m First Close of AVF, a New Fund Dedicated to Innovative Animal Health and Nutrition

MAR 20, 2018
Bayer and Ginkgo Bioworks Unveil Joint Venture, Joyn Bio, and Establish Operations in Boston and West Sacramento
Finance

Bayer and Ginkgo Bioworks Unveil Joint Venture, Joyn Bio, and Establish Operations in Boston and West Sacramento

MAR 20, 2018
Pivot Bio Announces Pre-Commercial Launch of Nitrogen-Producing Microbes to Improve Crop Nutrition and Yields
Phytobiome & Environment

Pivot Bio Announces Pre-Commercial Launch of Nitrogen-Producing Microbes to Improve Crop Nutrition and Yields

MAR 20, 2018
Biocodex Microbiota Foundation Awards Grants to Two Innovative Researchers in the Microbiome Field
Pharma & Human Health

Biocodex Microbiota Foundation Awards Grants to Two Innovative Researchers in the Microbiome Field

MAR 20, 2018
Arcadia Biosciences Achieves Key Resistant Starch Wheat Technology Milestones, Prepares for Commercial Launch
Pharma & Human Health

Arcadia Biosciences Achieves Key Resistant Starch Wheat Technology Milestones, Prepares for Commercial Launch

MAR 14, 2018
ExeGi Pharma Launches High Potency Veterinary Probiotic To Help Manage GI Tract Illnesses In Dogs
Animal Health

ExeGi Pharma Launches High Potency Veterinary Probiotic To Help Manage GI Tract Illnesses In Dogs

MAR 13, 2018
CosmosID Appoints Arne Materna as Vice President of Product
Pharma & Human Health

CosmosID Appoints Arne Materna as Vice President of Product

MAR 8, 2018
On World Kidney Day Centaur Pharmaceuticals & Kibow Biotech, USA, Announce a Strategic Alliance to Market Renadyl in India for Chronic Kidney Illness
Pharma & Human Health

On World Kidney Day Centaur Pharmaceuticals & Kibow Biotech, USA, Announce a Strategic Alliance to Market Renadyl in India for Chronic Kidney Illness

MAR 8, 2018